These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 6967946)

  • 21. Expression of HLA-DR, MB, MT and SB antigens on human mononuclear cells: identification of two phenotypically distinct monocyte populations.
    Nuñez G; Giles RC; Ball EJ; Hurley CK; Capra JD; Stastny P
    J Immunol; 1984 Sep; 133(3):1300-6. PubMed ID: 6611370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies reactive with class II antigens encoded for by the major histocompatibility complex inhibit human B cell activation.
    Clement LT; Tedder TF; Gartland GL
    J Immunol; 1986 Apr; 136(7):2375-81. PubMed ID: 3485149
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.
    Litwin V; Gumperz J; Parham P; Phillips JH; Lanier LL
    J Exp Med; 1993 Oct; 178(4):1321-36. PubMed ID: 8376937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SB: a new HLA-linked human histocompatibility gene defined using HLA-mutant cell lines.
    Kavathas P; DeMars R; Bach FH; Shaw S
    Nature; 1981 Oct; 293(5835):747-9. PubMed ID: 6974827
    [No Abstract]   [Full Text] [Related]  

  • 25. Strong lymphoproliferative suppressive function of PLT clones specific for SB-like antigens.
    Pawelec G; Wernet P; Rosenlund R; Blaurock M; Schneider EM
    Hum Immunol; 1984 Mar; 9(3):145-57. PubMed ID: 6199336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homozygous deletions that simultaneously eliminate expressions of class I and class II antigens of EBV-transformed B-lymphoblastoid cells. I. Reduced proliferative responses of autologous and allogeneic T cells to mutant cells that have decreased expression of class II antigens.
    DeMars R; Chang CC; Shaw S; Reitnauer PJ; Sondel PM
    Hum Immunol; 1984 Oct; 11(2):77-97. PubMed ID: 6092300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clonal analysis of HLA-DPw1 (SB1) associated allodeterminants: recognition of novel epitopes and evidence for quantitative variation in class II antigen expression.
    Eckels DD; Johnson AH; Hartzman RJ; Dacek D
    Hum Immunol; 1986 Feb; 15(2):234-50. PubMed ID: 2419289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human T cell receptor-gamma delta-expressing T-cell lines recognize MHC-controlled elements on autologous EBV-LCL that are not HLA-A, -B, -C, -DR, -DQ, or -DP.
    Lam V; DeMars R; Chen BP; Hank JA; Kovats S; Fisch P; Sondel PM
    J Immunol; 1990 Jul; 145(1):36-45. PubMed ID: 1694208
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxic T cells directed against HLA-DR antigens and their surface proteins.
    Burakoff SJ; Clayberger C; Hemler M; Krensky AM; Reiss CS; Robbins E; Sanchez-Madrid F; Springer TA; Strominger JL; Ware CF
    Diagn Immunol; 1983; 1(3):116-9. PubMed ID: 6238749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SB-restricted presentation of influenza and herpes simplex virus antigens to human T-lymphocyte clones.
    Eckels DD; Lake P; Lamb JR; Johnson AH; Shaw S; Woody JN; Hartzman RJ
    Nature; 1983 Feb; 301(5902):716-8. PubMed ID: 6186920
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of four SB antigens by cloned cells. Population studies of Norwegians.
    Moen T; Bratlie A; Kiss E; Bruserud O; Thorsby E
    Tissue Antigens; 1983 Oct; 22(4):298-309. PubMed ID: 6228036
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of T-lymphoblast-encoded HLA-DR, MT, and SB antigens on human T-B lymphoblast hybrids.
    Howell DN; Hartzman RJ; Cresswell P
    Hum Immunol; 1983 Oct; 8(2):167-75. PubMed ID: 6417070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cellular basis of anti-SB response.
    Ohta N; Reinsmoen NL; Bach FH
    Hum Immunol; 1984 Nov; 11(3):127-41. PubMed ID: 6083998
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular organization of the HLA-SB region of the human major histocompatibility complex and evidence for two SB beta-chain genes.
    Gorski J; Rollini P; Long E; Mach B
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):3934-8. PubMed ID: 6330724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a specific HLA DR2 Ia molecule as a restriction element for measles virus-specific HLA class II-restricted cytotoxic T cell clones.
    Jacobson S; Nepom GT; Richert JR; Biddison WE; McFarland HF
    J Exp Med; 1985 Jan; 161(1):263-8. PubMed ID: 2578544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recognition of a polymorphic monocyte antigen in HLA.
    van Leeuwen A; Termijtelen A; Shaw S; van Rood JJ
    Nature; 1982 Aug; 298(5874):565-7. PubMed ID: 6980374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural relationship of the SB beta-chain gene to HLA-D-region genes and murine I-region genes.
    Long EO; Gorski J; Mach B
    Nature; 1984 Jul 19-25; 310(5974):233-5. PubMed ID: 6431294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Divergent expression of HLA-DC/MB, -DR, and -SB region products on normal and pathological tissues as detected by monoclonal antibodies.
    Müller C; Ziegler A; Muller C; Hadam M; Waller HD; Wernet P; Müller G
    Immunobiology; 1985 Apr; 169(3):228-49. PubMed ID: 3873401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HLA-D region-associated determinants serve as targets for human cell-mediated lysis.
    Feighery C; Stastny P
    J Exp Med; 1979 Feb; 149(2):485-94. PubMed ID: 84045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.